Institutional Ownership
Anbio Biotechnology
CUSIP G0367B105SHS CL ANNNNQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
8
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 25.8K | $661.9K |
| 2 | Bnp Paribas Financial Markets | 10.4K | $267.2K |
| 3 | Morgan Stanley | 7.3K | $188.5K |
| 4 | Ubs Group AG | 6.3K | $162.8K |
| 5 | Eversource Wealth Advisors, LLC | 266 | $6.8K |
| 6 | Wells Fargo & Company/Mn | 100 | $2.6K |
| 7 | Bare Financial Services, Inc | 15 | $385 |
| 8 | Blue Trust, Inc. | 5 | $128 |